News Research Diagnostics & Imaging Glucose Monitoring & Insulin Delivery Ethics, Regulation, and Responsible Use

AACE Endocrine AI Weekly News Brief: April 6-10

April 10, 2026 By AACE Endocrine AI staff 3 min watch
Share Share via Email Share on Facebook Share on LinkedIn Share on Twitter

The AACE Endocrine AI Weekly News Brief for the week of April 6-April 10 features the findings of a new study on how AI video scribes may reduce medication omissions, promising research into how AI systems could lead to drug de-escalation in diabetes care, and a cautionary study on how artificial intelligence misinformation has the potential to decrease the diagnostic accuracy of novice medical students.

This week’s brief covers:

To learn more about AI video scribes, read "Video AI scribes may reduce medication omissions."

For more information on AI's potential in drug de-escalation in diabetes care, read "AI system linked to diabetes drug de-escalation."

To learn more about the impact of AI misinformation on novice medical students, read "Study: AI misinformation 'significantly' lowers diagnostic accuracy in novice medical students."



Disclaimer: This newscast was generated with the assistance of AI tools and avatars. All content is reviewed and approved by the editorial staff of AACE Endocrine AI. Contact us with any questions.

The ideas and opinions expressed in AACE Endocrine AI do not necessarily reflect those of Conexiant or AACE. The mention of any company, product, service, or therapy should not be construed as an endorsement of any kind. Conexiant and AACE assume no responsibility for any injury or damage to persons or property arising out of or related to any use of material contained in this publication or to any errors or omissions.

Related Content